IRVINE - Allergan Aesthetics, an AbbVie company (NYSE: ABBV), the makers of BOTOX Cosmetic (onabotulinumtoxinA), is celebrating 25 years of SkinMedica.
'For 25 years, SkinMedica has been delivering scientifically based skincare to patients and helping them to unlock the potential to have beautiful skin,' said Jasson Gilmore, Senior Vice President of U.S. Aesthetics at Allergan Aesthetics. 'We want to thank everyone who is a part of the SkinMedica family from its founders to our scientists, our employees, our customers and of course, everyone who uses SkinMedica!'
Since 1999, SkinMedica has developed high-quality, science-backed formulas that deliver visible results. The initial product launch of Dermal Repair Cream was soon followed by the groundbreaking TNS Recovery Complex, TNS Essential Serum, and TNS Advanced+ Serum, establishing the brand as a fixture in the industry. Throughout its evolution, SkinMedica would continue to introduce new, innovative formulations to SkinMedica loyalists and newcomers for years to come.
'Twenty-five years ago, we founded SkinMedica with a vision-to create a skincare line that's both scientific and luxurious, yet easy to use,' reflected Dr. Kimberly Butterwick, a double board-certified dermatologist and SkinMedica co-founder. 'Our breakthrough TNS product, developed through a unique process that harnessed growth factors, transformed SkinMedica from a startup into a brand known for innovation and excellence.'
'Beautiful skin is timeless,' Dr. Butterwick continues. 'For 25 years, SkinMedica has helped people feel more confident in their own skin, and I continue to count on them to provide science-based solutions to address my patients' key skincare concerns. As we celebrate this anniversary, I look forward to seeing how SkinMedica continues to innovate and provide exceptional skincare in the next 25 years.'
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas immunology, oncology, neuroscience, and eye care and products and services in our Allergan Aesthetics portfolio.
Forward-Looking Statements
Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words 'believe,' 'expect,' 'anticipate,' 'project' and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, and changes to laws and regulations applicable to our industry. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie's operations is set forth in Item 1A, 'Risk Factors,' of AbbVie's 2023 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its subsequent Quarterly Reports on Form 10-Q. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.
Contact:
Liz Shea
Email: Liz.Shea@AbbVie.com
Tel: (847) 935-2211
Ember Garrett
Email: Ember.Garrett@allergan.com
Tel: (714) 246-3525
ABBVIE INC. 
